336 related articles for article (PubMed ID: 25590605)
1. Relationship between tumor size and survival in non-small-cell lung cancer (NSCLC): an analysis of the surveillance, epidemiology, and end results (SEER) registry.
Zhang J; Gold KA; Lin HY; Swisher SG; Xing Y; Lee JJ; Kim ES; William WN
J Thorac Oncol; 2015 Apr; 10(4):682-90. PubMed ID: 25590605
[TBL] [Abstract][Full Text] [Related]
2. Prognostic significance of tumor size in patients with stage III non-small-cell lung cancer: a surveillance, epidemiology, and end results (SEER) survey from 1998 to 2003.
Morgensztern D; Waqar S; Subramanian J; Gao F; Trinkaus K; Govindan R
J Thorac Oncol; 2012 Oct; 7(10):1479-84. PubMed ID: 22982648
[TBL] [Abstract][Full Text] [Related]
3. A nomogram model to predict death rate among non-small cell lung cancer (NSCLC) patients with surgery in surveillance, epidemiology, and end results (SEER) database.
Jia B; Zheng Q; Wang J; Sun H; Zhao J; Wu M; An T; Wang Y; Zhuo M; Li J; Yang X; Zhong J; Chen H; Chi Y; Zhai X; Wang Z
BMC Cancer; 2020 Jul; 20(1):666. PubMed ID: 32680464
[TBL] [Abstract][Full Text] [Related]
4. Revisiting stage IIIB and IV non-small cell lung cancer: analysis of the surveillance, epidemiology, and end results data.
William WN; Lin HY; Lee JJ; Lippman SM; Roth JA; Kim ES
Chest; 2009 Sep; 136(3):701-709. PubMed ID: 19318668
[TBL] [Abstract][Full Text] [Related]
5. Pulmonologist involvement, stage-specific treatment, and survival in adults with non-small cell lung cancer and chronic obstructive pulmonary disease.
Deepak JA; Ng X; Feliciano J; Mao L; Davidoff AJ
Ann Am Thorac Soc; 2015 May; 12(5):742-51. PubMed ID: 25760983
[TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of visceral pleural involvement in early-stage lung cancer.
Lakha S; Gomez JE; Flores RM; Wisnivesky JP
Chest; 2014 Dec; 146(6):1619-1626. PubMed ID: 25032521
[TBL] [Abstract][Full Text] [Related]
7. A nomogram to predict the survival of stage IIIA-N2 non-small cell lung cancer after surgery.
Mao Q; Xia W; Dong G; Chen S; Wang A; Jin G; Jiang F; Xu L
J Thorac Cardiovasc Surg; 2018 Apr; 155(4):1784-1792.e3. PubMed ID: 29554790
[TBL] [Abstract][Full Text] [Related]
8. Volume-based parameters of (18)F-fluorodeoxyglucose positron emission tomography/computed tomography improve outcome prediction in early-stage non-small cell lung cancer after surgical resection.
Hyun SH; Choi JY; Kim K; Kim J; Shim YM; Um SW; Kim H; Lee KH; Kim BT
Ann Surg; 2013 Feb; 257(2):364-70. PubMed ID: 22968069
[TBL] [Abstract][Full Text] [Related]
9. Postoperative survival and the number of lymph nodes sampled during resection of node-negative non-small cell lung cancer.
Ludwig MS; Goodman M; Miller DL; Johnstone PA
Chest; 2005 Sep; 128(3):1545-50. PubMed ID: 16162756
[TBL] [Abstract][Full Text] [Related]
10. Performance status and smoking status are independent favorable prognostic factors for survival in non-small cell lung cancer: a comprehensive analysis of 26,957 patients with NSCLC.
Kawaguchi T; Takada M; Kubo A; Matsumura A; Fukai S; Tamura A; Saito R; Maruyama Y; Kawahara M; Ignatius Ou SH
J Thorac Oncol; 2010 May; 5(5):620-30. PubMed ID: 20354456
[TBL] [Abstract][Full Text] [Related]
11. Treatment of clinical T4 stage superior sulcus non-small cell lung cancer: a propensity-matched analysis of the surveillance, epidemiology, and end results database.
Wen J; Liu D; Chen D; Chen J; Xu X; Chen C; Zhang F; Duan S; Zhu R; Fan M; Chen Y
Biosci Rep; 2019 Feb; 39(2):. PubMed ID: 30647107
[No Abstract] [Full Text] [Related]
12. Five-year survival does not equal cure in non-small cell lung cancer: a Surveillance, Epidemiology, and End Results-based analysis of variables affecting 10- to 18-year survival.
Hubbard MO; Fu P; Margevicius S; Dowlati A; Linden PA
J Thorac Cardiovasc Surg; 2012 Jun; 143(6):1307-13. PubMed ID: 22361247
[TBL] [Abstract][Full Text] [Related]
13. The lymph node ratio predicts cancer-specific survival of node-positive non-small cell lung cancer patients: a population-based SEER analysis.
Kai L; Zhoumiao C; Shaohua X; Zhao C; Zhijun L; Zhengfu H; Xiujun C
J Cardiothorac Surg; 2021 Jan; 16(1):13. PubMed ID: 33468199
[TBL] [Abstract][Full Text] [Related]
14. [Value of metastatic lymph node ratio in predicting the prognosis of non-small cell lung cancer patients].
Li Y; Sun BS; Zhang ZF; Zhang LM; Wang CL
Zhonghua Yi Xue Za Zhi; 2011 Jun; 91(24):1682-6. PubMed ID: 21914316
[TBL] [Abstract][Full Text] [Related]
15. Prognostic impact of malignant pleural effusion at presentation in patients with metastatic non-small-cell lung cancer.
Morgensztern D; Waqar S; Subramanian J; Trinkaus K; Govindan R
J Thorac Oncol; 2012 Oct; 7(10):1485-9. PubMed ID: 22982649
[TBL] [Abstract][Full Text] [Related]
16. The prognostic value of ratio-based lymph node staging in resected non-small-cell lung cancer.
Qiu C; Dong W; Su B; Liu Q; Du J
J Thorac Oncol; 2013 Apr; 8(4):429-35. PubMed ID: 23486264
[TBL] [Abstract][Full Text] [Related]
17. Outcomes following surgical treatment compared to radiation for stage I NSCLC: a SEER database analysis.
Monirul Islam KM; Shostrom V; Kessinger A; Ganti AK
Lung Cancer; 2013 Oct; 82(1):90-4. PubMed ID: 23910907
[TBL] [Abstract][Full Text] [Related]
18. Thermal ablation matches sublobar resection outcomes in older patients with early-stage non-small cell lung cancer.
Kwan SW; Mortell KE; Talenfeld AD; Brunner MC
J Vasc Interv Radiol; 2014 Jan; 25(1):1-9.e1. PubMed ID: 24365502
[TBL] [Abstract][Full Text] [Related]
19. T1/T2 non-small-cell lung cancer treated by lobectomy: does tumor anatomic location matter?
Whitson BA; Groth SS; Andrade RS; Habermann EB; Maddaus MA; D'Cunha J
J Surg Res; 2012 Oct; 177(2):185-90. PubMed ID: 22921916
[TBL] [Abstract][Full Text] [Related]
20. Prognosis of Stage II non-small cell lung cancer according to tumor and nodal status at diagnosis.
Wisnivesky JP; Henschke C; McGinn T; Iannuzzi MC
Lung Cancer; 2005 Aug; 49(2):181-6. PubMed ID: 16022911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]